RBMY1 Activators
RBMY1 Activators encompass a group of chemical compounds that enhance the functional activity of RBMY1 through modulation of various signaling pathways and cellular processes. Forskolin, through the elevation of cAMP, activates PKA which could phosphorylate proteins that interact with RBMY1, thus enhancing its role in RNA splicing. Staurosporine, as a kinase inhibitor, potentially lifts inhibitions on RBMY1, allowing for increased splicing activity, while Calyculin A and Okadaic Acid maintain RBMY1 in a phosphorylated state by inhibiting protein phosphatases, which is associated with heightened splicing function. PMA, through PKC activation, and Ionomycin, by raising intracellular calcium levels, could both lead to phosphorylation events that promote RBMY1's activity.
RBMY1 Activators are a collection of chemical entities designed to amplify the activity of the RBMY1 splicing factor through targeted modulation of intracellular signaling cascades and phosphorylation events. Forskolin acts by increasing intracellular cAMP, which in turn activates PKA; this kinase is likely to phosphorylate proteins that regulate RBMY1, thereby enhancing its splicing activity. Similarly, Staurosporine, though a general kinase inhibitor, may preferentially relieve negative regulatory kinases that impact RBMY1, resulting in an upswing in its splicing activity. The inhibitors Calyculin A and Okadaic Acid obstruct protein phosphatases 1 and 2A, respectively, ensuring RBMY1 remains in a phosphorylated state conducive to its splicing role. Conversely, PMA activates PKC which could phosphorylate and thereby activate RBMY1, while Ionomycin elevates intracellular calcium to stimulate calcium-dependent kinases that may target RBMY1 for activation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which activates PKA. PKA can then phosphorylate various substrates, potentially including those that interact with or modify RBMY1 activity, leading to an enhancement in RBMY1's function in RNA splicing. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent non-selective inhibitor of protein kinases. By inhibiting specific kinases that negatively regulate splicing factors, staurosporine may indirectly enhance the splicing activity of RBMY1. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A acts as an inhibitor of protein phosphatases 1 and 2A. By preventing dephosphorylation, it can maintain RBMY1 in a phosphorylated state, potentially enhancing its activity as a splicing factor. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits protein phosphatases. This inhibition could lead to a hyperphosphorylated state of splicing factors, including RBMY1, which may result in increased splicing activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate serine and threonine residues on target proteins. Phosphorylation by PKC may enhance the activity of RBMY1 in its role in RNA processing. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases could phosphorylate RBMY1, thus promoting its splicing activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases and might prevent the inactivation of RBMY1 by these kinases, leading to sustained RBMY1 activity in RNA processing. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a lipid signaling molecule that activates G-protein coupled receptors, potentially influencing signaling pathways that modulate the activity of RNA splicing factors like RBMY1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is an inhibitor of protein synthesis and also activates MAPK pathways. Activation of these pathways could lead to enhanced phosphorylation and activation of splicing factors, including RBMY1. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific PKC inhibitor. By selectively inhibiting PKC isoforms that negatively regulate splicing factors, it could indirectly enhance RBMY1 activity. | ||||||